A new study has revealed that most Australian women of reproductive age prescribed GLP-1 receptor agonists, medications increasingly used for weight loss, such as Ozempic, are not using effective contraception, despite known risks during pregnancy
Mochi Health markets aggressively on social media and has built a recognizable brand, but its two-fee pricing structure and dose-dependent medication costs create a moving target for patients trying to budget their treatment
(PubMed) Zhou J, Austin RC
Long-term safety data continues to accumulate, and a comprehensive 2024 review in Diabetes Care by Daniel Drucker concluded that the overall risk-benefit profile of GLP-1 medicines remains favorable for their approved indications
Novo Nordisks Volume Play: In direct response, Novo Nordisk dramatically lowered the self-pay price for Wegovy